Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

Summary

Phase Ib, single centre, double-blind, double-dummy placebo-controlled, randomised, stepwise dose escalated, vaccine trial to assess the safety and immunogenicity of the candidate ChAdOx1 Chik and ChAdOx1 Zika vaccines, given as a standalone vaccines or in co-administration. Healthy volunteers aged 18-50 years old, residents of the metropolitan area of Monterrey (Mexico), will be recruited as participants

Timeline

Start

2020-10-23

Primary completion

2022-02-18

Completion

2022-02-18

Drugs

Indications